Oncolytics Today Spring 2022

Publication Highlights

HARNESSING TECHNOLOGY NCODA Informatics Initiative, Artificial Intelligence and Precision Medicine Provide Powerful New Tools in the World of Oncology. Page 48

President’s Message: THE COMING OF SPRING BRINGS MANY NEW AND EXCITING DEVELOPMENTS FOR NCODA. Page 6

NCODA CoE MIP Accreditation Interest and participation in NCODA’s new accreditation program is soaring. Page 8

The Promise of PROTACS Proteolysis-Targeting Chimeras offer a new therapeutic prospect for oncology. Page 10

NCODA University Education initiative will serve patients, members, industry partners & students. Page 15

PQI Podcast: DIGITAL MONITORING STRATEGY BOOSTS SYMPTOM RESPONSE IN PATIENT-REPORTED OUTCOMES STUDY. Page 20

Pharmacy Operations An enterprise approach to community oncology pharmacy operations. Page 21

OPTA: OPTA OFFERS PHARMACY TECHNICIANS VALUE IN TRAINING AND COLLABORATION. Page 23

Small-Molecule Inhibitors Pharmacologic considerations and treatment approaches for CLL. Page 25

How Can I Pay For This? The challenge of oral chemo parity. Page 34

The PAN Foundation Supporting cancer patients and advocating for affordability since 2004. Page 36

Executive Adv. Board Profile: BRENDA NEVIDJON. Page 37

State Legislation Tracking Tool Legislative & Policy Advisory Committee tool first-of-its-kind within oncology. Page 38

Chemotherapy Allergies Pharmacogenomics can help predict potential adverse effects. Page 39

Executive Council Profiles: MEET TWO OF NCODA’S EXECUTIVE COUNCIL LEADERS; Ray Bailey, BPharm, RPh and Paul Chadwick, BA. Page 42

Treatment Support Kits: NCODA OPTIMIZES TSK INITIATIVE TO ENSURE THE HIGHEST LEVELS OF QUALITY CONTROL. Page 60

The Human Microbiome A look at a new dimension and hallmark of cancer research. Page 63

Black Pain in America Black patients experience gaps in care due to disparities in healthcare system. Page 67

New Drug Roundup: FDA ANNOUNCES 8 ORAL ONCOLYTIC APPROVALS IN 4TH QUARTER 2021 AND 1ST QUARTER 2022. Page 70

NCODA & ONS How two organizations collaborate to share their interprofessional expertise. Page 74

Nursing Committee: PATIENTS ON ORAL ONCOLYTICS ARE ENTITLED TO THE SAME NURSING CARE AS THOSE ON IV TREATMENTS … So, Where are the Nurses? Page 82

Pharmacy Bottlenecks COVID-related challenges still linger in the wake of the pandemic. Page 85

‘Donut Hole’ Navigators Pharmacy technicians play an essential role in Medicare assistance for patients. Page 87

Industry Partner Profile: KIM SMITH | AstraZeneca. Page 89

Practice in Focus: CONE HEALTH CANCER CENTER AT WESLEY LONG. Page 95

Patient Success Story Pharmacist beat cancer to start family, now he fights to help co-survivors. Page 96

Final Word: A SEASON OF GROWTH: NCODA PROGRAMS & INITIATIVES OFFER GREAT OPPORTUNITIES. Page 98